Measuring methylphenidate response in attention-deficit/hyperactvity disorder: How are laboratory classroom-based measures related to parent ratings?

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 6, 2009, Pages 691-698

  Sonuga Barke, Edmund J S ^a,b   Coghill, David ^c   Debacker, Marc ^d   Swanson, James ^e  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UCB PHARMA   (Belgium)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARENT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL; SCHOOL CHILD; SEX DIFFERENCE; TASK PERFORMANCE; THERAPY EFFECT; TREATMENT RESPONSE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; LABORATORIES; MALE; METHYLPHENIDATE; OBSERVATION; PARENTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; SCHOOLS; SEX CHARACTERISTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77049103578     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2009.0027     Document Type: Article

References (29)

1. Abikoff H, Courtney M, Pelham WE, Koplewicz HS: Teachers' ratings of disruptive behaviors: The influence of halo effects. J Abn Child Psychol 21:519-533, 1993.
2. American Psychiatric Association: Diagnostic amd Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington (DC): American Psychiatric Association, 1994.
3. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJS, Taylor E: Longacting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatr 15:476-495, 2006.
4. Briggs-Gowan MJ, Carter AS, Schwab-Stone M: Discrepancies among mother, child, and teacher reports: Examining the contributions of maternal depression and anxiety. J Abn Child Psychol 24:749-765, 1996.
5. Bussing R, Gary FA, Mills TL, Garvan CW: Parental explanatory models of ADHD; Gender and cultural variations. Soc Psychiatr Psychiatr Epidemiol 38:563-575, 2003.
6. Coghill DR, Rhodes SM, Matthews K: The neuropsychological effects of chronicmethylphenidate on drug-naive boys with attention-deficit/ hyperactivity disorder. Biol Psychiatry 62:954-962, 2007.
7. Demaray MK, Elting J, Schaefer K: Assessment of attention-deficit/ hyperactivity disorder (ADHD): A comparative evaluation of five, commonly used, published rating scales. Psychol Schools 40:341-361, 2003.
8. Faraone SV, Monuteaux MC, Biederman J, Cohan SL, Mick E: Does parental ADHD bias maternal reports of ADHD symptoms in children? J Cons Clin Psychol 71:168-175, 2003.
9. Hartung CM, Van Pelt JC, Armendariz ML, Knight LA: Biases in ratings of disruptive behavior in children: Effects of sex and negative halos. J Atten Dis 9:620-630, 2006.
10. Madaan V, Daughton J, Lubberstedt B, Mattai A, Vaughan BS, Kratochvil CJ: Assessing the efficacy of treatments for ADHD- Overview of methodological issues. CNS Drugs 22:275-290, 2008.
11. Martins S, Tramontina S, Polanczyk G, Eizirik M, Swanson, JM, Rohde L: Weekend holidays during methylphenidate use in ADHD children: A randomized clinical trial. J Child Adolesc Psychopharmacol 14:195-206, 2004.
12. National Collaborating Centre for Mental Health: Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults: NICE clinical guideline. London: National Institute for Health and Clinical Excellence, 72; 2008.
13. Reid R, Maag JW: How many fidgets in a pretty much: A critique of behavior rating scales for identifying students with ADHD. J School Psychol 2:339-1254, 1994.
14. Rimmer M, Campbell C, Coghill D: ADHD: The impact on parent's and children's quality of life. Am Acad Child Adoles Psychiatr Ann Meeting Boston, 2007.
15. Simonoff E, Pickles A, Hervas A, Silberg, JL, Rutter M, Eaves L: Genetic influences on childhood hyperactivity: Contrast effects imply parental rating bias, not sibling interaction. Psychol Med 28:825-837, 1998.
16. Snyder SM, Hall JR, Cornwell SL: Review of clinical validation of ADHD behavior rating scales. Psychol Rep 99:363-378, 2006.
17. Sonuga-Barke EJS, Minocha K, Taylor E, Sandberg S: Inter ethnic bias in teachers' ratings of childhood hyperactivity. Br J Dev Psychol 11:187-200, 1993.
18. Sonuga-Barke EJS, Swanson J, Coghill D, DeCory H, Hatch S: Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: Preliminary indications from a secondary analysis of the COMACS study data. BMC Psychiatr 4:28, 2004.
19. Sonuga-Barke E, Coghill D, Markowitz J, Swanson J, Vandenberghe M, Hatch S: Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate. J Am Acad Child Adolesc Psychiatr 46:701-710, 2007.
20. Sonuga-Barke EJS, Van Lier P, Swanson JM, Coghill D, Wigal S, Vandenberghe M, Hatch S: Heterogeneity in the pharmacodynamics of two long-acting methylphenidate formulations for children with attention deficit/hyperactivity disorder: A growth mixture modelling analysis. Europ Child Adolesc Psychiatr 17:245-254, 2008.
21. Swanson J, Wigal S, Greenhill L, Browne R, Waslick B, Lerner M, Williams L, Flynn D, Agler D, Crowley KL, Fineberg E, Regino R, Baren M, Cantwell D: Objective and subjective measures of pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled analog classroom setting. Psychopharmacol Bull 34:55-60, 1998.
22. Swanson JM, Volkow ND: Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD. Behav Brain Res 130:73-78, 2002.
23. Swanson J, Wigal SB, Wigal T, Sonuga-Barke EJS, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ, COMACS study group: A comparison of two extended release preparations of methylphenidate; pharmacodynamic effects across the day. Pediatrics 113:e205-e215, 2004.
24. Swanson JM: School-based assessments and interventions for ADD students. Irvine (California): KC Publishing, 1992.
25. Taylor EA, Sonuga-Barke EJS: Disorders of Attention and Activity. In: Rutter's Child & Adolescent Psychiatry, 5th ed. Edited by Rutter M, Bishop D, Pine D, Scott S, Stevenson JS, Taylor EA, Thapar A. UK: Wiley-Blackwell, 2008; 521-542.
26. Taylor EA, Doepfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A: European Guidelines for Hyperkinetic Disorder-first upgrade. Europ Child Adolesc Psychiatr 13:7-30, 2004.
27. Wigal S, Gupta S, Guinta D, Swanson J.: Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacol Bull 34:47-53, 1998.
28. Wigal S, Wigal TL: The laboratory school protocol: Its origin, use, and new applications. J Atten Dis 10:92-111, 2006.
29. Wolraich, ML, Doffing MA: Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate. CNS Drugs 18:243-250, 2004.